Management of giant cell lesions.
Kaban
L B
LB
Dodson
T B
TB
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D006101:Granuloma, Giant Cell / Q000145:classification / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008439:Maxillary Diseases / Q000145:classification / Q000628:therapy*; D012008:Recurrence
D050071:Bone Density Conservation Agents; D007155:Immunologic Factors; D016898:Interferon-alpha; D002116:Calcitonin